EUDRAGIT - Rofarma
EUDRAGIT . Acrylic Polymers for Solid Oral Dosage Forms EUDRAGIT Technical Formulation Proof of GMP Advanced 1Products 2Support 3. Development 4 Concept 5 Services 6Drug Delivery Evonik. Power to create. When it comes to targeted drug release profiles, EUDRAGIT . is the pharmaceutical industry's preferred choice of product. The range of EUDRAGIT Poly(meth)acrylate-based products provides full flexibility for your solid oral dosage forms. EUDRAGIT Polymers . Pharmaceutical Properties The basis of our offerings are masking to increase patient A distinction is made between 2. Poly(meth)acrylates; inso- our Poly(meth)acrylates for compliance. The range of our 1. Poly(meth)acrylates; soluble luble but permeable in digestive pharmaceutical applications, product portfolio provides full in digestive fluids by salt forma- fluids EUDRAGIT RL and RS.
Controlled release: EUDRAGIT® enables formulations which allow customer-tailored release profiles and releases over a specific period of time. Sustained-Release Formulations
Download EUDRAGIT - Rofarma
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Release from Lamivudine Extended Release Matrix Tablets, Cogswell Outstanding Industrial Security Achievement Awards, Defense Security Service, PRESS RELEASE, RELEASE, New Teacher Induction, Sustained, WAIVER AND RELEASE FROM LIABILITY, Chromatographic method for miconazole assay, Oral sustained release mucoadhesive tablets